ANN ARBOR - Michigan’s life sciences industry grew into a $28 billion sector over decades, but it took the pandemic for many in the state to recognize just how essential it is. “Obviously we’re the industry that’s in the bull’s-eye of it all, whether it’s trying to come up with a vaccine or manufacturing enough PPE (Personal Protective Equipment)
ANN ARBOR—Officials of Swift Biosciences, a developer of gene sequencing technology, and BillionToOne, a Menlo Park, Calif. diagnostics company, announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day. The test is designed to detect
GRAND RAPIDS — Grand Valley State University's Kirkhof College of Nursing received a $500,000 grant from the Michigan Health Endowment Fund to offer a unique model of integrated behavioral health and primary care to a vulnerable population in Grand Rapids. The two-year grant establishes Project Thrive and offers fully integrated services at the GVSU Family
LANSING - Pharmaceutical companies would have to report to the state and the public annually how they set the prices of their prescription drugs under an eight-bill transparency package approved by the Michigan House Health Policy Committee. But the committee rejected, in party-line fashion, several attempts by Democrats to put more teeth into the bills,
LANSING—Connected Nation Michigan, the state’s unit of the broadband advocacy group Connected Nation, will host a webinar on telehealth usage and advances for patients and doctors on Tuesday, Sept. 22. The event, set to begin at 11 a.m. Eastern time, will feature a discussion with Ryan Palmer, chief of the Telecommunications Access Policy Division within
ANN ARBOR—Terumo Cardiovascular, a cardiovascular surgery products provider, announced a collaboration with Monmouth Junction, N.J.-based CytoSorbents Corp., to sell the latter company’s product CytoSorb to hospitals in 10 COVID-19 hotspot states. The states are Alabama, Arizona, California, Georgia, Louisiana, Mississippi, New Mexico, Oregon, Texas, and Washington. The product is designed to treat cytokine storm, a
ANN ARBOR - Eran Bashan, CEO of Hygieia, explains how his d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app
LIVONIA - With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program. “Ninety percent
ANN ARBOR - Infectious disease expert Fred Brown tells you what to do should you want to fly on a commercial aircraft flight to avoid catching COVID-19 and giving it to anyone else. President | Chief Operating Officer Fred Brown Management Consulting C-suite strategy and operations consulting to healthcare providers, insurers and suppliers. • COO
ANN ARBOR—The Biotechnology Innovation Organization (BIO), the life science industry’s trade and lobbying group, has released its ninth biennial report, “The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities,” which highlights Michigan as a top state for the biosciences. The report studies the state of the U.S. bioscience industry and its associated innovation
